NM_138694.4:c.1694-32C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_138694.4(PKHD1):​c.1694-32C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0355 in 1,609,904 control chromosomes in the GnomAD database, including 1,349 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 78 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1271 hom. )

Consequence

PKHD1
NM_138694.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.608

Publications

2 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 6-52055761-G-C is Benign according to our data. Variant chr6-52055761-G-C is described in ClinVar as Benign. ClinVar VariationId is 262390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0765 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138694.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKHD1
NM_138694.4
MANE Select
c.1694-32C>G
intron
N/ANP_619639.3
PKHD1
NM_170724.3
c.1694-32C>G
intron
N/ANP_733842.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKHD1
ENST00000371117.8
TSL:1 MANE Select
c.1694-32C>G
intron
N/AENSP00000360158.3
PKHD1
ENST00000340994.4
TSL:5
c.1694-32C>G
intron
N/AENSP00000341097.4

Frequencies

GnomAD3 genomes
AF:
0.0257
AC:
3903
AN:
152142
Hom.:
78
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00678
Gnomad AMI
AF:
0.183
Gnomad AMR
AF:
0.0157
Gnomad ASJ
AF:
0.0231
Gnomad EAS
AF:
0.00462
Gnomad SAS
AF:
0.0828
Gnomad FIN
AF:
0.0108
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0374
Gnomad OTH
AF:
0.0211
GnomAD2 exomes
AF:
0.0331
AC:
8217
AN:
248304
AF XY:
0.0363
show subpopulations
Gnomad AFR exome
AF:
0.00559
Gnomad AMR exome
AF:
0.0143
Gnomad ASJ exome
AF:
0.0202
Gnomad EAS exome
AF:
0.00489
Gnomad FIN exome
AF:
0.0136
Gnomad NFE exome
AF:
0.0386
Gnomad OTH exome
AF:
0.0304
GnomAD4 exome
AF:
0.0366
AC:
53293
AN:
1457644
Hom.:
1271
Cov.:
30
AF XY:
0.0381
AC XY:
27659
AN XY:
725190
show subpopulations
African (AFR)
AF:
0.00539
AC:
180
AN:
33398
American (AMR)
AF:
0.0154
AC:
685
AN:
44574
Ashkenazi Jewish (ASJ)
AF:
0.0212
AC:
552
AN:
26080
East Asian (EAS)
AF:
0.00192
AC:
76
AN:
39664
South Asian (SAS)
AF:
0.0832
AC:
7151
AN:
85930
European-Finnish (FIN)
AF:
0.0145
AC:
772
AN:
53208
Middle Eastern (MID)
AF:
0.0350
AC:
195
AN:
5570
European-Non Finnish (NFE)
AF:
0.0378
AC:
41869
AN:
1108994
Other (OTH)
AF:
0.0301
AC:
1813
AN:
60226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
2081
4162
6244
8325
10406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1564
3128
4692
6256
7820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0257
AC:
3907
AN:
152260
Hom.:
78
Cov.:
32
AF XY:
0.0259
AC XY:
1930
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00676
AC:
281
AN:
41550
American (AMR)
AF:
0.0157
AC:
240
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
80
AN:
3470
East Asian (EAS)
AF:
0.00463
AC:
24
AN:
5180
South Asian (SAS)
AF:
0.0833
AC:
401
AN:
4816
European-Finnish (FIN)
AF:
0.0108
AC:
115
AN:
10618
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0374
AC:
2545
AN:
68006
Other (OTH)
AF:
0.0213
AC:
45
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
197
394
590
787
984
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0180
Hom.:
11
Bravo
AF:
0.0251
Asia WGS
AF:
0.0420
AC:
148
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive polycystic kidney disease Benign:1
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:1
Jul 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Polycystic kidney disease 4 Benign:1
Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.45
DANN
Benign
0.36
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12196276; hg19: chr6-51920559; COSMIC: COSV107435525; API